Back to mobile site

Credit Suisse Downgrades ZS Pharma (ZSPH) to Neutral on Takeover

November 9, 2015 6:24 AM EST Send to a Friend
Credit Suisse downgraded ZS Pharma (NASDAQ: ZSPH) from Outperform to Neutral with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login